Perspectives on the development of neutralizing antibodies against SARS-CoV-2
Perspectives on the development of neutralizing antibodies against SARS-CoV-2
About this item
Full title
Author / Creator
Publisher
United States: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
SARS-CoV-2 gains entry to human cells through its spike (S) protein binding to angiotensin-converting enzyme 2 (ACE2). Therefore, the receptor binding domain (RBD) of the S protein is the primary target for neutralizing antibodies. Selection of broad-neutralizing antibodies against SARS-CoV-2 and SARS-CoV is attractive and might be usef...
Alternative Titles
Full title
Perspectives on the development of neutralizing antibodies against SARS-CoV-2
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7291920
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7291920
Other Identifiers
ISSN
2516-4236
E-ISSN
2516-4236
DOI
10.1093/abt/tbaa009
